| Issue Type | XXXX |
|---|---|
| Country | South Korea |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2026-09-03 |
| Par Value | |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 120000.00 |
| Coupon | 2.194 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 120000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Samsung Biologics Co Ltd corporate bond has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million KRW and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Samsung Biologics Co Ltd, founded in 2011 and headquartered in Incheon, South Korea, is a leading biopharmaceutical company dedicated to providing high-quality contract development and manufacturing services (CDMO) for biopharmaceutical products. The company specializes in the manufacturing of monoclonal antibodies and recombinant proteins and is recognized for its state-of-the-art facilities and advanced technology in the bioprocessing sector.